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  Transmissible spongiform encephalopathies (TSEs), or prion diseases, are a group of incurable 
neurodegenerative disorders, including Kuru and Creutzfeldt-Jakob disease in humans, “mad cow” 
disease in cattle, and scrapie in sheep. This paper presents structural, genetic, and evolutionary 
evidence supporting an endogenous TSE virus model that integrates the three major traditional 
views on the nature of TSE pathogens, the conventional virus view, the prion hypothesis, and the 
virino concept, into a novel conceptual and evolutionary framework. According to this model, the 
TSE pathogens are symbiotic endogenous viruses that inadvertently produce transmissible viral 
particles that lack the viral genome and are composed primarily of the viral prion protein (PrP). 
Production of defective viral particles that contain a partial genome or lack the viral genome entirely 
is a relatively common event in the life cycle of many viruses. Similar to the normal viral particles, 
which contain a genome, these defective viral particles can be transmitted to new host cells. 
Obviously, in the absence of viral genome, these protein-only viral particles cannot establish a 
productive infection. However, if these viral particles enter a host cell that carries the parental or a 
related virus and induce the production of similar protein-only particles, then they would appear as 
self-replicating, protein-only infectious pathogens if mistakenly taken out from the context of the 
viral life cycle. This misconception, which is rooted into the current dogma of viruses as viral 
particles, led to the development of the prion theory. The endogenous TSE virus model is consistent 
with the TSE data and offers solutions to many enigmatic features associated with TSE, including the 
function of PrP that, despite more than two decades of TSE research conducted primarily within the 
framework of the prion hypothesis, is still not known. According to the TSE endogenous virus model, 
PrP is the protein of an endogenous virus that has co-evolved with their vertebrate hosts by 
providing a protective function against pathogenic viruses. The evidence for the endogenous TSE 
virus model and for the antiviral protective function of PrP is strong, and they are fully open to 
additional experimental testing. The endogenous virus model opens the TSE research field to new 
interpretations and directions, both in basic research and in associated biomedical and public health 
fields, and could lead to development of new diagnostic and therapeutic approaches. 
               ______________________________________________________________________________________ 
 
Introduction 
 Transmissible spongiform encephalopathies (TSEs), or 
prion diseases, are a group of incurable neurodegenerative 
disorders, including Kuru and Creutzfeldt-Jakob disease in 
humans, bovine spongiform encephalopathy, or “mad cow” 
disease in cattle, and scrapie in sheep (1;2). Despite 
considerable progress in understanding the pathology, 
transmission, and the genetics of TSE, the nature of the 
TSE pathogens is enigmatic. Based on biological and 
biochemical properties, such as strain variation and 
resistance to denaturing agents, heat, and radiation, three 
rival views about the nature of the TSE pathogens have 
been proposed [reviewed in (3-17)].  
 Consistent with the viral etiology of similar diseases, the 
TSE pathogens were initially regarded as viruses with 
unique properties and a long incubation period. However, 
as early as the 1960s, it was speculated that TSE pathogens 
might lack a nuclei acid-based genome and might be 
composed entirely of carbohydrates, lipids, proteins, or 
more intricate biochemical complexes such as 
glycoproteins or cellular membranes (18-20). One of these 
early ideas, that of a “replicating protein”(20), was later 
developed into the prion hypothesis (12;21). This 
hypothesis claims that TSE are caused by a novel type of 
infectious pathogens, called prions, which consist of a self-
replicating protein identified as proteinase K-resistant 
structural isoform (commonly referred to as PrP-res, or 
PrPSc) of a cellular glycoprotein (PrP) (12;22).  The virino 
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concept was developed in the 1970s based on an earlier 
“replication site” hypothesis for scrapie agent 
(15;16;23;24). According to this concept, the TSE 
pathogens are low molecular weight nucleic acid 
molecules, probably small RNAs, which replicate and are 
transmitted in a complex with a host protein (a product of 
Sinc locus in mice) that was later identified as PrP.   
 It is apparent, however, that neither of these traditional 
views about the nature of TSE pathogens can fully explain 
the current TSE data [discussed in (3-17)]. This data is 
more consistent with an endogenous TSE virus model, in 
which the TSE pathogens are germ-line or endogenous 
viruses that inadvertently produce transmissible viral 
particles (TSE-VPs) composed primarily of the endogenous 
viral PrP and lacking a viral genome (25). This model is 
strongly supported by the fact that most if not all viruses 
produce viral particles that contain a partial viral genome, 
or lack the viral genome entirely; interestingly, some of 
these defective particles, referred to as “interfering 
particles,” can co-infect new host cells and interfere with 
the life cycle of co-infecting parental or related viruses 
(26;27) [for a general review of this and other facts about 
viruses see (28)].  
 Obviously, in the absence of a viral genome, these 
protein-only defective viral particles cannot establish a 
productive infection. However, if these viral particles enter 
a host cell that carries the parental or a related viral genome 
and induce the production of similar particles, they would 
appear as self-replicating, protein-only infectious pathogens 
if mistakenly taken out of the context of the viral life cycle. 
As previously suggested (25), this misconception, which is 
rooted in the dogma of viruses as viral particles (see 
below), led to the development of the prion theory - the 
leading working hypothesis in the TSE research field for 
more than two decades. 
 This paper presents additional evidence and arguments 
for the endogenous TSE virus model and offers solutions to 
many enigmatic TSE features, such as the function of PrP. 
The paper begins with a brief discussion of the misleading 
dogma of viruses as viral particles, which has played a 
critical role in the historical development of the views about 
the nature of TSE pathogens. Next, the paper presents 
structural, genetic, and evolutionary evidence for the 
endogenous TSE virus model, and it outlines the 
implications of this model for TSE research and public 
health, including development of new diagnostic and 
therapeutic approaches. 
 
The dogma of viruses as viral particles and the nature of 
TSE pathogens 
 Since their discovery at the turn of the last century, 
viruses have been identified with and defined based on the 
properties of their viral particles [reviewed in (29;30)]. The 
viral particles are highly specialized viral structures used by 
many viruses for their transmission to new host cells. 
However, not all viruses produce viral particles. Some use 
alternative modes of transmission, such as vertical  
Box 1. Quotations illustrating the critical role played by 
the dogma of viruses as viral particles in the development 
of hypotheses about the nature of TSE pathogens, 
particularly in the development of prion hypothesis:  
 
Quote 1 [from ]: “To avoid prejudging the structures of 
these infectious particles, prions were defined as “small 
proteinaceous infectious particles that resist inactivation by 
procedures which modify nucleic acids” and three 
hypothetical structures for the prion were proposed: (i) 
proteins surrounding a nucleic acid that encodes them (a 
virus) (ii) proteins surrounding a small non-coding 
polynucleotide, and (iii) a proteinaceous particle devoid of 
nucleic acid. Data from many laboratories have established 
that scrapie is not caused by a virus.”a
 
Quote 2 [from (12)]: “Although both prions and viruses 
multiply, their properties, structures, and modes of 
replication seem to be fundamentally different. Viruses 
contain nucleic acid genomes that encode progeny viruses; 
proteins necessary for producing infectious viruses are 
encoded by the viral genome. In contrast, prions contain 
little or no nucleic acid, and PrP is encoded by a cellular 
gene.” 
_______________ 
aAs pointed out in this (12) and other publications (11;13;31), 
initially, the concept of “prion” included viruses. Only later, due 
to lack of evidence for a TSE associated viral genome did the 
concept of prion evolved to specifically stand for a protein-only, 
non-viral pathogen. As described in the following quote from 
reference (32), the development of prion concept was challenging: 
“The discovery of prions and their eventual acceptance by the 
community of scholars represents a triumph of the scientific 
process over prejudice.” It is within the spirit of this process that 
the endogenous TSE virus model is proposed here as an 
alternative to prion hypothesis.  
 
transmission from mother to daughter cells (28;33-35). 
Moreover, the defining biological properties of all viruses, 
whether they do or do not produce viral particles, are 
expressed during the intracellular stage of their life cycle 
when they replicate their genomes and synthesize their 
specific molecules, many of which are not components of 
the viral particles. As discussed in detail in two other papers 
of this series on the origin and evolution of cellular and 
viral domains  [reviewed in (30;36)], the dogma of viruses 
as viral particles misrepresents the nature of viruses and 
sets them outside the mainstream biological and 
evolutionary paradigms. Moreover, this dogma has led to 
misconceptions that have constrained the full progress in 
some biomedical fields. One of the most pragmatic 
examples is the TSE field, which is discussed here. 
 In order to define the nature of the TSE pathogens in 
context of the dogma of viruses as viral particles, the TSE 
studies focused on the composition and properties of TSE 
transmissible units [Box 1; see also (3-17)]. Accordingly, 
central to the historical debate about the viral or non-viral 
nature of the TSE pathogens was the presence or absence of 
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nucleic acids (i.e. viral genome) associated with these 
pathogens. During the last few decades, hundreds of TSE 
studies addressed this issue. The vast majority of these 
studies have shown that the TSE agents do not contain a 
viral genome and, therefore, according to the dogma of 
viruses as viral particles they could not be viruses. Based on 
the results of these studies, the prion theory became the 
leading working hypothesis in the TSE field (32). 
According to this hypothesis, prions are non-viral, protein-
only infectious agents (see Box 1), which replicate by a 
mechanism in which the PrP-res molecules induce by a 
direct template-based mechanism the conversion of cellular 
PrP into new PrP-res (37).  
 The endogenous TSE virus model (25), which was 
inspired by a new view about the nature and evolutionary 
origin of viruses (29), was based on well-documented facts 
about the  life cycle of many viruses and on additional lines 
of evidence and reasoning. At that time, it was well known 
that viruses make defective viral particles that could enter 
new host cells and interact with the life cycle of co-
infecting parental or related viruses (26;27). It was also 
well documented that humans and other vertebrates host 
numerous germ-line, or endogenous viruses, some of which 
produce viral particles [reviewed in (33)]. Based on these 
facts, and on the rationale that it is highly unlikely that 
cellular genes would evolve to produce pathogenic, 
infectious products, I proposed that the TSE pathogens are 
endogenous viruses, suggestively labeled prionic viruses, 
that produce transmissible, protein-only viral particles (25). 
These particles would appear to be self-propagating if, upon 
entering new host cells, they activate the parental or a 
related endogenous virus to produce similar particles. This 
activation process is the key for understanding the 
mechanism of producing new TSE-VPs and for 
understanding the TSE phenomenon. As proposed next, this 
process is analogous to a common mechanism for self-
assembly of viral particles found in many virus families. 
 
A virus-like mechanism for the assembly of TSE 
transmissible units 
 In viruses that make viral particles, the structure, 
biochemical composition, and the overall complexity of 
these particles are highly diverse [see (28)]. Fundamentally, 
however, the morphogenesis of many types of viral 
particles is based on the self-assembly of viral protein 
monomers into polymeric structures (38-41). In some 
viruses, this process requires the participation of 
chaperoning or scaffolding viral proteins and of the viral 
genome (38-41). It is important to emphasize that similar to 
the assembly of viral proteins into viral particles, the 
assembly of many cellular proteins into molecular 
complexes is dictated not only by their primary amino-acid 
sequence (i.e. by the genetic information), but also by 
interactions with other molecules, such as other proteins, 
nucleic acids, or lipids that could act as chaperons, 
scaffolds, or templates for their correct folding and 
assembly (42;43).  
 During the self-assembly of some viral particles, the 
capsid protein monomers undergo isomeric conformational 
changes rich in β-sheet domains. These β-sheet domains are  
a common feature in viral capsid proteins to the extent that, 
despite little or no primary amino acid sequence homology 
among capsid proteins of different viruses, this feature is 
used as critical evidence for inferring evolutionary 
relationships among viral families across the three cellular 
kingdoms, Archaea, Bacteria, and Eukarya (44;45). 
Interestingly, the β-sheet-based protein domains are also the 
main structural change during PrP isomeric conformational 
transition to PrP-res (37;46).   Additionally, efficient self-
assembly of viral particles in many viral species requires a 
viral genome, or nonspecific nucleic acid molecules (38-
41;47), a phenomenon that is also observed during 
assembly of the transmissible TSE units (48-55) [reviewed 
in (56;57)]. There is also very strong evidence that PrP has 
structural and functional properties similar to those of 
retroviral proteins (50;51;58).  
 Another piece of evidence supporting the idea that the 
TSE transmissible structures are analogous to viral particles 
is the finding that these units contain 14 to 28 isomeric 
monomers of PrP (17-27 nm particles) and that single 
monomers or particles containing fewer than five 
monomers do not induce TSE (59). Taken together, these 
findings support the hypothesis that the TSE transmissible 
units are structures analogous to viral particles, and that the 
mechanism for their assembly mimics that of the viral 
particle. This might explain the common finding of virus-
like particles in TSE tissues and cell culture (60-64). 
 Although some of these findings are circumstantial, they 
are consistent with an endogenous TSE virus model in 
which the TSE transmissible units are the viral particles 
(TSE-VPs) of an endogenous virus. The TSE-VPs are 
composed of isomeric conformational monomers of PrP 
labeled here PrP-vp. The structure of PrP-vp might be 
similar but likely not identical to that of PrP-res found in 
the TSE-associated amyloid plaques. In the endogenous 
TSE virus model, the native PrP molecules use the 
incoming TSE-VPs and possibly additional molecules, such 
as non-specific nucleic acid molecules, as scaffolds, 
templates, or chaperons for self-assembly into new 
transmissible TSE-VPs. 
 For reasons that will become more transparent in the 
following sections, in context of the endogenous TSE virus 
model, the generation of new TSE transmissible units (i.e. 
TSE-VPs) is regarded as an intrinsic property and activity 
of the native PrP molecules rather than of the incoming 
TSE-VPs, which is a subtle but highly significant departure 
from the current view. Likely, the PrP-res and their 
aggregates, the amyloid plaques, are byproducts of the 
TSE-VPs assembly process; this scenario is consistent with 
the results of numerous studies showing a poor correlation 
between the amount of PrP-res and TSE transmission or 
pathology, a finding that has been used as strong evidence 
against the prion theory [reviewed in (4;13)]. Interestingly, 
some human TSEs can be caused by protease sensitive 
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isoforms of PrP (65), reinforcing the idea that the PrP-res 
and its amyloid plaques might not be essential for infection 
and pathogenesis. 
 
Genetic and evolutionary evidence for the endogenous 
TSE virus model  
 The gene coding for PrP, the PRNP, which was 
identified in the hamster and mouse genome as a single 
chromosomal gene, was found in all examined vertebrate 
species (66-68). The phylogenetic analysis of PRNP in 
mammals, birds, reptiles, and fish showed that the evolution 
of PRNP mirrors the established evolutionary relationships 
among the vertebrate species, suggesting that this gene was 
present early in the vertebrate lineage and has been 
relatively stable during evolution. This stability is reflected 
also by a similar molecular architecture of PrP protein in 
vertebrates (69). However, some additional genes similar to 
PRNP, such as the doppel gene in humans and SPRN in 
mammals and fish, have been discovered [reviewed in 
(68)]. These findings are consistent with the hypothesis that 
the endogenous TSE virus had entered the germ line of 
vertebrates very early in their evolution and has diversified 
along with vertebrate lineages.  
 One of the most striking features of the PRNP and 
related genes is the lack of introns within the protein coding 
region of the gene. This is a relatively rare phenomenon 
among vertebrate genes, but highly predictable for viral 
genes. The PRNP chromosomal region contains numerous 
endogenous retroviral sequences and transposable elements 
(68;70), which makes it difficult to uncover other potential 
clues associated with the organization and expression of 
PRNP that would indicate a viral origin. Interestingly, 
though, the PRNP contains several sequence domains that 
are similar and collinear to domains in the retroviral reverse 
transcriptase gene (71). The full significance of this 
sequence similarity remains to be revealed. Taken together, 
these genetic features are consistent with PRNP being an 
endogenous viral gene.  
 The strain repertoire of TSE pathogens, relating to 
features such as incubation period, pathology, and tissue 
tropism, is a remarkable feature [reviewed in (3;4;7;14;72-
74)]. Although in many cases the strain specificity of newly 
formed TSE transmissible units appears to be dictated by 
the incoming TSE units, in some animal models this 
specificity is apparently a function of the native PrP 
[reviewed in (3;4;7;14;72-74)]. It is possible, however, that 
in addition to PrP, nucleic acid molecules, such as small 
RNAs [discussed in (3;55;75)], might participate as 
chaperons or scaffolds during the assembly of new TSE 
transmissible units (i.e. TSE-VPs), contributing to TSE 
strain specificity even though they might not be included in 
the transmissible units (Box 2). Similarly, the assembly of 
viral particles in many viral species requires participation of 
viral molecules that act as chaperons or scaffolds (38-41). 
Interestingly, the participation of chaperone protein 
molecules, which are not included in the transmissible 
forms, has been demonstrated in yeast prions (76;77). 
Box 2. The current experimental data  supports the 
hypothesis that nucleic acid molecules (NAs) participate in 
TSE [discussed in  (3;55;75)].  To evaluate this hypothesis, 
both conceptually and experimentally, it is critical to 
define: 
 
(a)  the  stage in the life cycle of TSE pathogens in    
  which these NAs participate, 
(b) whether NAs participate as structural or as     
  informational molecules, or both, and  
(c)  the source of these NAs. 
 
As I previously emphasized [see comments in (78)], 
combining these features generates a rather complex set of 
potential hypothetical models for the participation of NAs 
such as small RNAs in TSE. Possibly, these TSE-associated 
RNAs (tse-RNAs) participate as chaperones in facilitating 
the assembly of new transmissible TSE viral particles 
(TSE-VPs). Moreover, these tse-RNAs might play an 
“informational role” by dictating the rate and/or the pattern 
of the assembly of PrP into new TSE-VPs, thereby 
conferring at least partially the strain characteristics of TSE 
pathogens. However, it is likely that the strain specificity of 
TSE pathogens is dictated primarily by the endogenous 
viral PrP molecules during their interaction with the 
incoming TSE-VPs (see text). The sequence of the 
hypothetical tse-RNAs is probably nonspecific, although 
their secondary structure might be a factor in dictating their 
chaperoning efficiency.  Some of these chaperoning tse-
RNAs might be included in the TSE-VPs as bystanders but, 
likely, they are not essential for TSE-VPs’ transmission to a 
new host.  Moreover, in this hypothetical model, the tse-
RNAs do not replicate; they are arbitrary transcripts 
encoded by the host or by endogenous viral genomic 
sequences for various reasons. 
                                                    
 
 The TSE strain phenomenon has been used as one of the 
strongest circumstantial evidence for the presence of a 
nucleic acid genome in the TSE transmissible units 
[discussed in (3-17;79)]. Considering the overwhelming 
evidence that the TSE transmissible units do not contain a 
viral genome, or that low molecular weight nucleic acids 
that could confer strain specificity have yet to be identified, 
this argument remains weak [see Box 2 and my comments 
in (78)].  
 However, the TSE strain diversity is still one of the 
strongest pieces of evidence against the prion hypothesis, 
but from an entirely different perspective. Based on a 
highly regarded observation that “Nothing in biology makes 
sense except in the light of evolution” (80), the prion theory 
would need to explain the evolution of a cellular protein 
that is: (a) pathogenic, (b) infectious, (c) able to transfer its 
structure and properties to new molecules by a template-
based mechanism, and (d) able to undergo multiple 
isomeric conformations that are pathogenic and infectious. 
Certainly, owing to physiological factors or to mutations 
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some cellular proteins can form amyloid-like aggregates 
that are pathogenic [reviewed in (43;81)]. It should be 
noted, however, that TSE amyloid plaques per se 
apparently are not neurotoxic, nor infectious; i.e. they are 
not the TSE pathogens. Therefore, an analogy between the 
TSE pathogens and other amyloid proteins might not be 
relevant. Although, evolutionarily, pathogenic genes that 
are expressed during the reproductive period of a species 
are usually selected against and eventually eliminated, it 
could be rationalized that if the PrP gene is an essential 
cellular gene, then its occasional pathogenic activity would 
be evolutionarily tolerated. However, the fact that some 
isomeric forms of PrP are not only pathogenic but also 
infectious requires yet another evolutionary explanation 
that is much more difficult to rationalize. Next, the prion 
hypothesis needs to address a highly intricate and difficult 
issue, which is explaining the evolution of a mechanism by 
which the PrP infectious units transfer their structure and 
properties to the native PrP molecules, often in a strain-
specific manner; the evolution of such an extraordinary 
feature would require strong selection. In summary, in 
order to remain a leading working hypothesis in the TSE 
field, the prion hypothesis must offer solutions to all these 
evolutionary issues. 
 Unlike the prion hypothesis, which doesn’t appear to 
have evolutionary support, the origin of endogenous TSE 
viruses is an evolutionary expected phenomenon (25;82) 
and, as proposed in the next section, the remarkable 
property of endogenous viral PrP to assume diverse 
isomeric conformations (which dictates the strain 
specificity of the TSE pathogens) has been specifically 
selected to fulfill an antiviral protective function. 
 
A protective, anti-viral function for endogenous viral 
PrP 
 Vertebrate species harbor thousands of germ-line 
retroviruses, some of which are evolutionally related across 
all vertebrates [reviewed in (83;84)]. Although most 
endogenous viruses are not active, some express their genes 
and even produce viral particles; however, little is known 
about their expression pattern (85-88). Based on well-
supported evolutionary principles of host-pathogen co-
evolution, it is expected that endogenous viruses that 
decrease the fitness of their host would be eliminated along 
with their host by natural selection. On the other hand, 
endogenous viruses that increase the fitness of their host 
would be able to thrive evolutionarily (3;89). 
 The evolutionary history of PRNP in vertebrates is 
evidence for strong selection, implying a significant 
function for PrP. Surprisingly, after more than two decades 
of research conducted within the framework of the prion 
theory, which is based on the idea that PRNP is a cellular 
gene, the function of PrP is still not known (90-93). 
Remarkably, under experimental conditions, mice lacking 
PRNP have a normal phenotype (94).  
 As previously emphasized, understanding the function of 
PrP is critical for understanding the nature of TSE 
pathogens [discussed in (69;75;95;96)]. Considering that 
endogenous viruses that are pathogenic cannot survive 
evolutionally, it is likely that PRNP has been selected to 
fulfill a symbiotic function [see also ref. (3)]. In the 
endogenous TSE virus model, an endogenous virus that 
entered the germ-line of vertebrates early in their evolution 
co-evolved with their hosts by providing protection against 
other viruses. This protective function was especially 
beneficial for neurological tissues, particularly the central 
nervous system, which have a limited potential for 
regeneration and, therefore, could not be under the normal 
surveillance of the immune system because of its associated 
deleterious inflammatory effects. The same rationale is also 
valid for the function and evolution of the doppel protein, a 
homolog of PrP, which is expressed primarily in the testes 
[reviewed in (68)].  
 The property of PrP molecules to undergo isoform 
transitions into new structural conformations and their 
propensity to interact with RNA molecules and assemble 
into particles (48-54) [reviewed in (56;57)] are clues not 
only to their viral evolutionary origin but also to potential 
mechanisms for their anti-viral function. Based on these 
properties, PrP could interfere with the entry of parasitic 
viruses, replication of their genome and expression of their 
genes, or with disassembly or assembly of their viral 
particles, potentially generating a multifaceted protective 
barrier against viral infection. Similar anti-viral protective 
mechanisms are found in the life cycle of many viruses, 
which protect their host cells, and themselves, from 
infection with competing viral species (89;97-100). A 
potential anti-viral mechanism of PrP could be based on its 
intrinsic properties to recognize and interact with the 
components of the pathogenic viruses, such as nucleo-
capsid monomers, by mimicking their structure. PrP would 
use these viral components as scaffolds, or chaperons, to 
adopt diverse isomeric conformations that by mimicking 
the structure and properties of the incoming viral nucleo-
capsid components would be able to disrupt the viral life 
cycle. To be able to exercise their protective mechanism 
against a variety of virulent viruses, including endogenous 
viruses, it is proposed here that the PrP molecules evolved 
the extraordinary property of adopting diverse isomeric 
conformations, which fundamentally explains the TSE 
strain phenomenon. 
 In the endogenous TSE-virus model, the transmissible 
units - the TSE-VPs - are recognized by the native 
endogenous viral PrP molecules as pathogenic viruses. The 
native PrP molecules use the incoming PrP-vp as 
chaperons, scaffolds, or templates to change their native 
structure into an isomeric conformation that mimics that of 
incoming PrP-vp. However, unlike the interactions of PrP 
with genuine pathogenic viruses, which would lead to their 
inactivation, the interaction of native PrP molecules with 
the incoming TSE-VPs (and probably also with 
chaperoning tse-RNAs; see Box 2) leads to their self-
assembly into new TSE-VPs, which continue the cycle. 
 Several lines of evidence indicate that neuro-
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degeneration and TSE pathogenesis is induced only when 
the endogenous viral PrP molecules are anchored on the 
cellular membrane by a glycosyl-phosphatidylinositol (GPI) 
moiety (101). Presumably, the process by which the 
membrane-anchored PrP molecules interact with one 
another and with the incoming TSE-VPs and, possibly, with 
additional chaperons during their assembly into the new 
TSE-VPs damages the cellular membranes, causing host 
cell death. Considering the potential cellular signaling 
properties of GIP-anchored proteins, it is conceivable that 
PrP could exercise an additional antiviral protective 
mechanism by triggering the death of infected host cells 
through apoptosis [reviewed in (7;72)] which would block 
the spread of infectious pathogenic viruses. 
 Although the protective function of the endogenous viral 
PrP was selected to be exercised primarily in neurological 
tissues, this molecule is also expressed in other tissues, such 
as immune cells, which explains the multiplication of TSE 
agents in the peripheral lymphoid tissue before reaching the 
central nervous system. Lack of clinical signs associated 
with multiplication of TSE agents in immune cells is 
enigmatic (7). However, TSE-associated pathology has 
been observed in lymphoid tissues (102;103), and evidence 
for a presumed antiviral PrP function against endogenous 
retroviruses in mouse spleens has been shown (75). A 
plausible explanation for the apparent lack of clinical 
symptoms associated with the assembly of new TSE-VPs in 
lymphoid tissue is the relatively high turnover of immune 
cells as compared to the cells in the neurological tissue. It 
would be expected, however, that TSE-associated cellular 
toxicity affects the immune memory cells, which is a 
testable hypothesis. The production of new TSE-VPs in the 
peripheral tissues seems to be necessary for their migration 
to the central nervous system, and it is proposed here that 
the elusive cellular receptor for the TSE-VPs in all cells 
types is the native PrP. Interestingly, PrP has been 
previously suggested as the receptor for TSE pathogens but 
from a different rationale, specifically to explain the 
essential requirement for PrP in TSE in context of the 
conventional virus hypothesis (4;13). 
 Similar to endogenous TSE viruses, other endogenous 
viruses have co-evolved with their hosts by providing anti-
viral protective functions [reviewed in (89;97-99)]. A well 
documented example is the murine endogenous viral gene 
Fv1, which is evolutionally related to the gag gene of the L 
family of murine endogenous retroviruses. Apparently, the 
product of Fv1 inhibits the infection by murine leukemia 
virus by a post-entry mechanism. Because Fv1 and other 
functionally related endogenous retroviral genes in 
mammals, including humans, have entered their host germ-
line more recently than PRNP, their homology with 
endogenous retroviruses is easier to detect. 
 Another interesting, circumstantial finding that is 
suggestive of an anti-viral protective function for PrP is the 
function of one of the yeast prions, the [Het-s], which was 
shown to protect their fungal host from infection by 
debilitating fungal viruses [reviewed in (104)]. However, 
there is strong, direct evidence that PrP interacts with other 
viruses and confers protection (58;75;105-112). For 
example, the production of HIV-1 in a human cell line 
expressing high levels of PrP was reduced eightfold, and 
HIV infectivity by three- to fourfold (58). Also, it was 
recently shown that activation of endogenous murine 
retroviruses in germinal centers of mouse spleens following 
immune-stimulation leads to up-regulation of PrP 
expression, which in turn reduces the level of retroviral 
activity (75). 
 There is no doubt that viruses have played a major role 
in the evolution of their hosts. Along with other parasites 
and pathogens, viruses have shaped the evolution of their 
hosts by parasitism and disease under the classical 
Darwinian selective pressures imposed by host-parasite co-
evolution. However, because of their ability to insert their 
genome into the host genome and to be transmitted 
vertically, endogenous viruses have shaped the evolution of 
their hosts by direct genomic mechanisms, including the 
contribution of viral genetic material, modulation of the 
host’s gene expression, and promoting recombination 
events [reviewed (84;113;114)]. Interestingly, most of the 
vertebrate genome is composed of non-coding DNA (nc-
DNA), or “junk DNA,” that in large part still maintains a 
retroviral signature [reviewed in (84;115;116)]. There is 
strong evidence that one of the major functions of ncDNA, 
including introns, is to protect the host genes from 
insertional mutagenic activity of proviruses and other 
mobile genetic elements by serving as a “sink” for their 
integration (117-119). This represents one of the most 
significant cases of host-virus co-evolution in which the 
host uses viral genetic material as an anti-viral defense 
mechanism. However, it is evident that this co-evolution 
also led to the development of a series of anti-viral 
protective mechanisms via viral proteins [reviewed in 
(89;97-99)], such as (a) the anti-viral resistance factors Fv1, 
Lv1 and Ref1 in mammals, (b) syncytin, a protein encoded 
by an endogenous virus that is apparently associated with 
multiple sclerosis (120) (note: similar to other predictable 
anti-viral proteins, syncytins are expressed primarily in 
tissues that are not under normal immune system 
surveillance), (c) possibly some of the interferon- and TNF-
families of proteins (121;122), and (d) the PrP and doppel 
proteins, as hypothesized here. 
 
Summary and Perspective 
 For more than two decades the prion theory, which 
outside the TSE field is usually regarded as fact, has been 
the leading working hypothesis in TSE research. However, 
numerous researchers in this field have questioned this 
theory, and many of them have supported the other 
traditional views about the nature of the TSE pathogens - 
the conventional virus view and the virino concept 
[discussed in (3-17;79)]. A legitimate question is why 
would different groups of highly regarded TSE researchers 
interpret basically the same experimental data in such 
disparate ways? As I discussed recently [see comments in  
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(78)], it is unconceivable that so many scientists  have been 
wrong for such a long period; this is unprecedented in the 
history of modern science. A sensitive answer is that these 
traditional views about the nature of the TSE pathogens are 
partially correct, but the problem is with the reductionist 
approach imposed by the current dogma of viruses as viral 
particles in evaluating the TSE phenomenon. 
 As pointed out here, one of the main objectives of the 
TSE research and the focus of the developing hypotheses 
and concepts about the nature of TSE pathogens has been 
the presence, or the absence, of a nucleic acid genome in 
the TSE transmissible, infectious units. Although practical 
from a medical and public health perspective, this focus on 
the infectious stage in the life cycle of infectious pathogens, 
particularly in the case of viruses, has obscured the 
relevance of the other life cycle stages in establishing their 
nature. This focus on the infectious stage in the life cycle of 
pathogens has created also the false expectation that the 
infectious forms should contain all the major structural and 
informational components of a pathogen, including their 
genome. However, for endogenous pathogens, which are 
vertically transmitted and therefore are present in all the 
host cells, this doesn’t necessarily need to be the case.  
 Failure to recognize these fundamental biological 
principles when conducting research and interpreting 
experimental data could lead to conflicting views [see 
comments in (78)]. For example, based on the 
overwhelming evidence that TSE infectious units do not 
contain a viral genome and, therefore, according to the 
dogma of viruses as viral particles they could not be 
defined as viruses (see Box 1), the prion hypothesis seemed 
justified despite the fact that it made little biological and 
evolutionary sense.  Similar concerns about the prion 
hypothesis have been expressed by many TSE researchers 
[discussed in (3-17;79)], leading to open contentions in the 
TSE research field (31;95;96). 
 The endogenous TSE virus model, which is rooted in a 
new view about the nature and evolution of viruses (29;82), 
integrates aspects of all three traditional views about the 
nature of TSE pathogens into a unifying scenario [see my 
comments in (78)]. This model might be a more effective 
working hypothesis in TSE field as compared the current 
hypotheses. The endogenous TSE virus model opens this 
field to new interpretations and directions, both in basic 
research and in associated biomedical and public health 
fields.  
 First of all, this model completely changes the 
perspective on TSE. In the endogenous TSE virus model, 
the generation of new infectious TSE units is regarded as an 
intrinsic property and activity of the native PrP molecules, 
rather than of the incoming TSE transmissible units. This 
perspective accommodates not only infectious TSE, but 
also provides the rationale for understanding inherited TSE 
such as familial Creutzfeldt-Jakob disease, which results 
from germ-line mutations in PRNP, and for understanding 
spontaneous TSE, which is the most common form of TSE 
in humans. Likely, spontaneous TSE is caused by somatic 
mutations in PRNP or by epigenetic factors that lead to 
spontaneous assembly of PrP into TSE-VPs, which induces 
a PrP antiviral response and consequently the production of 
new TSE-VPs. 
 Evidently, TSE strain variation and inter-species 
transmission patterns are more effectively explained in the 
context of the endogenous TSE virus model than in that of 
the other hypotheses. Moreover, this model sets up a 
conceptual framework for considering a similar endogenous 
viral etiology for other disorders, such as Alzheimer’s, 
Parkinson’s, and Huntington’s diseases. Interestingly, it 
was recently found that the PrP has a protective role against 
development of Alzheimer’s disease (123), suggesting 
subtle, but significant interactions among endogenous viral 
elements. 
 From a medical and public health perspective, the 
endogenous viral nature of the TSE pathogens and their 
potential interaction with other viruses, both exogenous and 
endogenous, is highly relevant as these interactions could 
lead to altered transmission patterns and to the evolution of 
new strains. Of particular interest is the possibility that PrP-
vp might be included into the viral particles of exogenous 
or endogenous viruses by mechanisms analogous to viral 
phenotypic mixing, which could enhance the horizontal 
transmission of TSE (124). This phenomenon might explain 
the enigmatic high rate of natural transmission of scrapie in 
sheep and wasting syndrome in elk (1;2). In addition to 
phenotyping mixing, genetic recombination of TSE 
endogenous viruses with other endogenous and exogenous 
retroviruses, could lead to new pathogenic viral strains 
(125-128). Certainly, highly pathogenic endogenous viruses 
would not survive evolutionally, but neither would their 
host, which might explain why pathogenic endogenous 
viruses are not commonly found.  
 An obvious advantage of the endogenous TSE virus 
model as compared to the traditional hypotheses is that it is 
consistent with the experimental evidence that previously 
has been used to specifically support these traditional 
views, and it integrates them into a unifying scenario about 
the nature of TSE [see also my comments in (78)]. 
Therefore, based strictly on the current experimental data, 
the endogenous TSE virus model might be a superior 
working hypothesis for TSE research compared with the 
prion hypothesis or the other views; this is highly 
significant, because productivity in any research field 
depends on the quality of the working hypothesis. 
Additional supporting evidence for the endogenous TSE 
virus model could be found by searching for other genetic 
features that would attest for the endogenous viral nature of 
PRNP, or from studying the assembly properties of the PrP 
molecules into viral particle-like structures and their 
interaction with other viruses. It is also possible that some 
extant viral lineages are evolving into TSE-like viruses, 
which would be the ultimate proof for the endogenous TSE 
virus model. 
 The endogenous TSE virus model makes several 
predictions, which are fully open to experimental testing. 
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The antiviral protective function of PrP is one of the most 
significant predictions. The current evidence for this 
function is strong, and considering the existence of 
numerous wild-type and PRNP knockout animal models, 
additional studies testing this hypothesis should be 
relatively straightforward. Additional predictions, such as 
the hypothesis that PrP serves as the cellular receptor for 
TSE infectious units or that TSE leads to depletion of 
immune memory cells, are also fully testable. One of the 
most significant implications of the endogenous TSE virus 
model and the presumed property of PrP to assemble into 
viral particles is that analogous viral processes could be 
used as model systems for developing new TSE diagnostic 
reagents and therapeutic approaches. 
 In conclusion, the endogenous TSE virus model provides 
a highly plausible conceptual and evolutionary framework 
for explaining, integrating, and directing TSE research, 
which could accelerate the progress towards understanding 
and controlling TSEs and related disorders. 
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